跳至主要内容
临床试验/EUCTR2020-005963-29-DK
EUCTR2020-005963-29-DK进行中(未招募)1 期

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial - ASCOT ADAPT

niversity of Melbourne0 个研究点目标入组 2,400 人开始时间: 2020年12月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
2,400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age above or equal 18 years
  • - Admitted to an acute-care hospital
  • - Confirmed SARS- CoV-2 by nucleid acid testing in the past 14 days
  • - Able to be randomised within 14 days of symptom onset
  • - At least one symptom or sign attributable to SARS-CoV-2 infection
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • - Currently receiving acute intensive respiratory support (Invasive or non-invasive ventilation) or vasopressor/inotropic support
  • - Previous participation in the trial
  • - Treating team deems enrolment in the study is not in the best interest of the patient
  • - Death is deemed to be imminent and inevitable within the next 24 hours

研究者

发起方
niversity of Melbourne

相似试验